| Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541) |
|---|
| 03/20/2003 | CA2460348A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites |
| 03/19/2003 | EP0956141B1 Amine heat stable salt neutralization having reduced solids |
| 03/19/2003 | CN1404384A Novel primary intermediate for use in oxidative hair dyeing |
| 03/19/2003 | CN1403455A Synthesis of 2-oxazolidone derivate by one still process |
| 03/19/2003 | CN1403439A Phytosphingosine derivate with antitumor activity |
| 03/18/2003 | US6534441 Nickel-rhenium catalyst for use in reductive amination processes |
| 03/18/2003 | US6533960 Reduction of carbonyl compounds by a silane in the presence of a zinc catalyst |
| 03/13/2003 | WO2002096901A3 1,3-dihydroxybenzene derivatives and colorants containing said compounds |
| 03/13/2003 | WO2002034708A3 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
| 03/13/2003 | US20030050316 An amine compound of phenyl or hetero ring for treating Alzheimer's disease |
| 03/12/2003 | EP1291340A1 Phytosphingosine derivatives with antitumor activity |
| 03/12/2003 | EP1291339A2 Continuous process for the synthesis of monoethanolamine, diethanolamine and triethanolamine |
| 03/12/2003 | EP1289929A1 Shortened synthesis of 3,3-diarylpropylamine derivatives |
| 03/12/2003 | EP1289927A1 Method for producing alkanolamines |
| 03/12/2003 | EP1289926A2 A novel process for preparing salmeterol |
| 03/12/2003 | EP1289514A1 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments |
| 03/12/2003 | CN1402702A Beta 2-adrenergic receptor agonists |
| 03/12/2003 | CN1401627A Process for preparing optically pure N-methyl-3-phenyl-3-hydoxypropylamine |
| 03/11/2003 | US6531610 Intermediate acylating carbonate |
| 03/11/2003 | US6531571 Method for the removal of excess amounts of water-soluble amines from mannich condensation products |
| 03/11/2003 | US6531567 Hardeners for epoxy resins |
| 03/11/2003 | US6531511 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission |
| 03/11/2003 | CA2022381C Process for preparing n-alkyl-substituted aminophenols |
| 03/06/2003 | WO2003018762A2 Compositions that bind antiterminator rna and their assays |
| 03/06/2003 | WO2003018531A1 Methods for the synthesis of amines such as ephedrine and intermediates |
| 03/06/2003 | WO2003018070A1 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 03/06/2003 | WO2003017955A1 Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives |
| 03/06/2003 | WO2002085877A3 Processes and intermediates for preparing benzyl substituted epoxides |
| 03/06/2003 | WO2002066415A8 Non-steroidal modulators of estrogen receptors |
| 03/06/2003 | US20030045727 Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups |
| 03/06/2003 | US20030045586 Use of amines |
| 03/06/2003 | US20030045583 Novel succinate salt of O-desmethyl-venlafaxine |
| 03/06/2003 | US20030041392 Process for making 1,4-diamino-2-methoxymethylbenzene and salts thereof and compositions and methods for dyeing keratin fibers containing same |
| 03/06/2003 | CA2458507A1 Compositions that bind antiterminator rna and their assays |
| 03/05/2003 | EP1287404A1 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method |
| 03/05/2003 | EP1287006A1 Antitumoral compounds |
| 03/05/2003 | CN1102561C Method of resolving racemic mixtures |
| 03/04/2003 | US6528686 Processes for producing optically active 2-amino-1-phenylethanol derivatives |
| 03/04/2003 | US6528685 Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| 02/27/2003 | WO2003016261A1 Substituted octahydrophenanthrene compounds and their use as nmda antagonists |
| 02/27/2003 | WO2002038105A3 Novel polyamine analog-amino acid conjugates useful as anticancer agents |
| 02/27/2003 | US20030040644 Synthesis of nitroalcohol diastereomers |
| 02/26/2003 | CN1399687A Method for producing optically active amines |
| 02/26/2003 | CN1399622A Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 02/25/2003 | US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 02/20/2003 | WO2003014061A1 Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions |
| 02/20/2003 | DE20217957U1 Oxidative dyeing agent for keratin fibers uses 2-aminomethylene-substituted resorcinols as couplers, some of which are novel compounds |
| 02/19/2003 | CN1398263A Method for prepn. of citaopram |
| 02/13/2003 | US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 02/12/2003 | EP1282592A2 Use of amines |
| 02/12/2003 | CN1396819A Novel coupler for use in oxidative hair dyeing |
| 02/06/2003 | US20030028026 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment |
| 02/06/2003 | US20030027869 Amine compounds and inhibiting neurotransmitter reuptake |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1280759A1 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them |
| 02/05/2003 | EP1127040B1 Methods and compositions for inhibiting polymerization of ethylenically unsaturated hydrocarbons |
| 02/05/2003 | EP1044183B1 Amination process |
| 02/05/2003 | CN1394855A Substituted heterocyclic compound |
| 02/05/2003 | CN1100768C Substituted diphenyl oxazolines |
| 02/04/2003 | US6515162 Method of preparing retroviral protease inhibitor intermediates |
| 02/04/2003 | US6515028 Glucamine compounds for treating hepatitis virus infections |
| 02/04/2003 | US6514995 Metal complex is capable of forming a benzenoid diradical under physiological conditions and/or under photothermal conditions |
| 01/30/2003 | WO2003008559A2 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders |
| 01/30/2003 | WO2003008371A1 Substituted 4-aminocyclohexanol derivatives |
| 01/30/2003 | WO2003008370A1 Substituted 4-aminocyclohexanols |
| 01/30/2003 | WO2003007929A1 Amine compounds and inhibiting neurotransmitter reuptake |
| 01/30/2003 | US20030022900 Compositions comprising alpha-1C specific compounds |
| 01/30/2003 | US20030022114 Method for preparing an acid salt of p-phenylenediamine-type photographic color developers |
| 01/29/2003 | EP1278716A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists |
| 01/28/2003 | US6511966 Administering for therapy of mitochondria medited disease |
| 01/28/2003 | CA2148839C Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
| 01/23/2003 | WO2003006449A1 Method for the preparation of escitalopram |
| 01/23/2003 | WO2003005965A2 Modulators of ceramidase and methods of use based thereon |
| 01/23/2003 | WO2002046138A3 Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines |
| 01/23/2003 | US20030018192 Preparation of substituted aromatic compounds |
| 01/23/2003 | US20030018083 Methods of treating and preventing pain, anxiety, and incontinence using derivatives of (-)-venlafaxine |
| 01/23/2003 | US20030017995 Dialysis solutions and methods |
| 01/23/2003 | US20030017426 Method for purifying free-base p-phenylenediamine-type photographic color developers |
| 01/23/2003 | US20030017093 Reaction apparatus for production of alkanolamine and method for production of alkanolamine using the apparatus |
| 01/22/2003 | EP0894123B1 Improvements in or relating to calixarenes |
| 01/22/2003 | CN1392876A Combretastatin A-4 phosphate prodrug, mono-and di-organic amine salt, mono-and di-amino acids salts, and mono-and di-amino acid ester salt |
| 01/21/2003 | US6509504 Method for the production of serinol |
| 01/21/2003 | US6509472 For use in enantioselective reduction of prochiral ketones to chiral secondary alcohols |
| 01/16/2003 | WO2003004454A1 Linked cyclitols and their polysulfated derivatives |
| 01/16/2003 | WO2002045658A3 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
| 01/16/2003 | WO2002029412A3 Selective binding materials |
| 01/16/2003 | US20030013892 Production of chirally pure alpha-amino acids and N-sulfonyl alpha-amino acids |
| 01/15/2003 | CN1098844C Substituted biphenyloxazolines |
| 01/14/2003 | US6506798 4-Arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective MEK inhibitors |
| 01/09/2003 | WO2003003115A1 Method for purifying free-base p-phenylenediamine-type photographic color developers |
| 01/09/2003 | WO2003002255A1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 01/09/2003 | WO2002018325A3 Process for the preparation of substituted phenylacetonitriles |
| 01/09/2003 | US20030008981 Adding aminophenol compound and nitroxyl radical compound for polymerization inhibition of olefins and diolefins |
| 01/09/2003 | US20030008889 Aminoadamantane derivatives as therapeutic agents |
| 01/09/2003 | US20030008859 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 01/09/2003 | US20030008360 Microorganisms for use in the generation of preferential cyclopentene |
| 01/08/2003 | CN1390194A Stable salts of novel derivatives of 3,3-diphenylpropylamines |
| 01/07/2003 | US6503945 Nontoxic, drug delivery, gene therapy; therapy of cystic fibrosis |
| 01/03/2003 | WO2003000636A1 Resolution process for (r)-(-)-2-hydroxy-2-(2-chlorophenyl) acetic acid |
| 01/02/2003 | US20030004360 Processes and intermediates for preparing benzyl epoxides |